Earnings

Travelzoo shares continue to face significant downward pressure, leaving investors questioning whether the decline has a foreseeable end. The company's...

Ionis Pharmaceuticals is experiencing a dramatic upward trajectory, with its stock performance capturing significant market attention. The biotech firm's impressive...

Absci finds itself navigating turbulent financial waters as the biotechnology firm grapples with plunging revenue alongside aggressive investment in its...

Investors in Akero Therapeutics are bracing for a pivotal moment as the biopharmaceutical company approaches a decisive regulatory deadline. With...

While numerous biotechnology firms are scaling back expectations, Supernus Pharmaceuticals is projecting a surprisingly confident stance by reaffirming its annual...

Biotechnology firm Equillium is executing a profound strategic overhaul, pivoting its entire operational focus to a single, promising drug candidate....

Cava Group, the restaurant chain operator, is confronting a significant downturn as its stock value hits a fresh 52-week low....

While numerous retailers face existential threats, Build-A-Bear Workshop demonstrates a masterclass in shareholder satisfaction. The experiential retailer has reaffirmed its...

The retail sector faces a pivotal moment as Target prepares to release its quarterly earnings, with shareholders anticipating potentially dramatic...

The global leader in logistics real estate, Prologis, continues to demonstrate its market dominance through another quarter of exceptional operational...